1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Rapid, efficient auxin-inducible protein degradation in Candida pathogens

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          A variety of inducible protein degradation (IPD) systems have been developed as powerful tools for protein functional characterization. IPD systems provide a convenient mechanism for rapid inactivation of almost any target protein of interest. Auxin-inducible degradation (AID) is one of the most common IPD systems and has been established in diverse eukaryotic research model organisms. Thus far, IPD tools have not been developed for use in pathogenic fungal species. Here, we demonstrate that the original AID and the second generation, AID2, systems work efficiently and rapidly in the human pathogenic yeasts, Candida albicans and Candida glabrata. We developed a collection of plasmids that support AID system use in laboratory strains of these pathogens. These systems can induce >95% degradation of target proteins within minutes. In the case of AID2, maximal degradation was achieved at low nanomolar concentrations of the synthetic auxin analog 5-adamantyl-indole-3-acetic acid. Auxin-induced target degradation successfully phenocopied gene deletions in both species. The system should be readily adaptable to other fungal species and to clinical pathogen strains. Our results define the AID system as a powerful and convenient functional genomics tool for protein characterization in fungal pathogens.

          IMPORTANCE

          Life-threatening fungal infections are an escalating human health problem, complicated by limited treatment options and the evolution of drug resistant pathogen strains. Identification of new targets for therapeutics to combat invasive fungal infections, including those caused by Candida species, is an urgent need. In this report, we establish and validate an inducible protein degradation methodology in Candida albicans and Candida glabrata that provides a new tool for protein functional characterization in these, and likely other, fungal pathogen species. We expect this tool will ultimately be useful for the identification and characterization of promising drug targets and factors involved in virulence and drug resistance.

          Related collections

          Most cited references52

          • Record: found
          • Abstract: found
          • Article: not found

          Hidden killers: human fungal infections.

          Although fungal infections contribute substantially to human morbidity and mortality, the impact of these diseases on human health is not widely appreciated. Moreover, despite the urgent need for efficient diagnostic tests and safe and effective new drugs and vaccines, research into the pathophysiology of human fungal infections lags behind that of diseases caused by other pathogens. In this Review, we highlight the importance of fungi as human pathogens and discuss the challenges we face in combating the devastating invasive infections caused by these microorganisms, in particular in immunocompromised individuals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Invasive candidiasis

            Invasive candidiasis is an important health-care-associated fungal infection that can be caused by several Candida spp.; the most common species is Candida albicans, but the prevalence of these organisms varies considerably depending on geographical location. The spectrum of disease of invasive candidiasis ranges from minimally symptomatic candidaemia to fulminant sepsis with an associated mortality exceeding 70%. Candida spp. are common commensal organisms in the skin and gut microbiota, and disruptions in the cutaneous and gastrointestinal barriers (for example, owing to gastrointestinal perforation) promote invasive disease. A deeper understanding of specific Candida spp. virulence factors, host immune response and host susceptibility at the genetic level has led to key insights into the development of early intervention strategies and vaccine candidates. The early diagnosis of invasive candidiasis is challenging but key to the effective management, and the development of rapid molecular diagnostics could improve the ability to intervene rapidly and potentially reduce mortality. First-line drugs, including echinocandins and azoles, are effective, but the emergence of antifungal resistance, especially among Candida glabrata, is a matter of concern and underscores the need to administer antifungal medications in a judicious manner, avoiding overuse when possible. A newly described pathogen, Candida auris, is an emerging multidrug-resistant organism that poses a global threat.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An auxin-based degron system for the rapid depletion of proteins in nonplant cells.

              Plants have evolved a unique system in which the plant hormone auxin directly induces rapid degradation of the AUX/IAA family of transcription repressors by a specific form of the SCF E3 ubiquitin ligase. Other eukaryotes lack the auxin response but share the SCF degradation pathway, allowing us to transplant the auxin-inducible degron (AID) system into nonplant cells and use a small molecule to conditionally control protein stability. The AID system allowed rapid and reversible degradation of target proteins in response to auxin and enabled us to generate efficient conditional mutants of essential proteins in yeast as well as cell lines derived from chicken, mouse, hamster, monkey and human cells, thus offering a powerful tool to control protein expression and study protein function.
                Bookmark

                Author and article information

                Contributors
                Role: InvestigationRole: MethodologyRole: Writing – original draftRole: Writing – review and editing
                Role: InvestigationRole: Writing – review and editing
                Role: InvestigationRole: MethodologyRole: Writing – review and editing
                Role: Investigation
                Role: Investigation
                Role: MethodologyRole: InvestigationRole: Writing – review and editing
                Role: Investigation
                Role: MethodologyRole: SupervisionRole: Writing – review and editing
                Role: MethodologyRole: Supervision
                Role: MethodologyRole: SupervisionRole: Writing – review and editing
                Role: MethodologyRole: SupervisionRole: Writing – review and editing
                Role: ConceptualizationRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: SupervisionRole: Writing – original draftRole: Writing – review and editing
                Role: Editor
                Journal
                mSphere
                mSphere
                msphere
                mSphere
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                2379-5042
                Sep-Oct 2023
                18 August 2023
                18 August 2023
                : 8
                : 5
                : e00283-23
                Affiliations
                [1 ] Department of Biochemistry, Purdue University; , West Lafayette, Indiana, USA
                [2 ] Department of Biomedical Sciences, Universidad de Extremadura; , Badajoz, Spain
                [3 ] Institute of Functional Biology and Genomics, Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Salamanca (USAL); , Salamanca, Spain
                [4 ] Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa; , Iowa City, Iowa, USA
                [5 ] Institute for Cancer Research, Purdue University; , West Lafayette, Indiana, USA
                University of Georgia; , Athens, Georgia, USA
                Author notes
                Address correspondence to Mark C. Hall, mchall@ 123456purdue.edu

                The authors declare no conflict of interest.

                Author information
                https://orcid.org/0000-0002-7163-1120
                https://orcid.org/0000-0003-2852-3594
                https://orcid.org/0000-0001-6429-2506
                Article
                00283-23 msphere.00283-23
                10.1128/msphere.00283-23
                10597344
                37594261
                a0ce0659-27a8-4d5a-b0d9-2965067e17c8
                Copyright © 2023 Milholland et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 25 May 2023
                : 30 June 2023
                Page count
                supplementary-material: 1, authors: 12, Figures: 5, References: 52, Pages: 16, Words: 8781
                Funding
                Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID);
                Award ID: AI136995
                Award Recipient :
                Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID);
                Award ID: AI152494
                Award Recipient :
                Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID);
                Award ID: AI168050
                Award Recipient :
                Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID);
                Award ID: T32AI148103
                Award Recipient :
                Funded by: Indiana Clinical and Translational Sciences Institute (CTSI);
                Award ID: UL1TR002529
                Award Recipient :
                Funded by: MEC | Agencia Estatal de Investigación (AEI);
                Award ID: PID2020-118109RB-I00
                Award Recipient :
                Funded by: EC | European Regional Development Fund (ERDF);
                Award ID: CL-EI-2021-08-IBFG
                Award Recipient :
                Categories
                Resource Report
                editors-pick, Editor’s Pick
                genetics-and-molecular-biology, Genetics and Molecular Biology
                Custom metadata
                September/October 2023

                auxin-inducible degradation,candida albicans,candida glabrata,cdc14,gcn5,mob2,targeted protein degradation

                Comments

                Comment on this article